Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11523-025-01138-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence.
Target Oncol
March 2025
Hospital Arnau de Vilanova, FISABIO, Valencia, Spain.
Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes.
Exp Oncol
February 2025
Department of Plastic and Reconstructive Oncourology, Nonprofit Organization "National Cancer Institute", Kyiv, Ukraine.
Background: Potential clinical efficacy of cystectomy in patients with metastatic bladder cancer (mBCa) remains poorly investigated. The clinical data suggest that there could be a benefit from the local treatment in selected patients with mBCa in terms of redeeming local symptoms, increasing quality of life (QoL), and decreasing the number of the potential adverse events of systemic therapy. The aim of our study was to test safety and efficacy of cystectomy in mBCa and its impact on patients' survival, QoL, and eligibility for systemic therapy.
View Article and Find Full Text PDFA systematic review of wide alveolar cleft repair techniques.
J Plast Reconstr Aesthet Surg
March 2025
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address:
Wide alveolar clefts impair secondary alveolar bone grafting due to deficient mucoperiosteal tissue for grafted bone coverage. Consequently, preparatory or alternative techniques are often required for closure of such defects. We conducted a PRISMA-adherent systematic literature review on wide alveolar cleft repair to compare treatment efficacies and patient populations.
View Article and Find Full Text PDFTIPS and hepatic encephalopathy in patients with cirrhosis.
Metab Brain Dis
February 2025
Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Hôpital de la Pitié Salpétrière, INSERM UMR_S 938, CDR Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
Despite a better understanding in its prognosis and pathogenesis, hepatic encephalopathy (HE) remains one of the major complications of Transjugular Intrahepatic Portosystemic Shunt (TIPS) with a prevalence ranging from 35 to 50%. Its epidemiology differs according to the indication for TIPS (salvage/rescue TIPS, preemptive (pTIPS) or elective TIPS). In salvage/rescue TIPS, the prognosis is linked to that of bleeding, and HE should not be a contraindication to TIPS, especially as bleeding is a common precipitating factor of HE.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!